Antinausea medication linked to improving breast cancer
Play
Stop
A recent study has found that the anti-nausea medication Aprepitant may do more than just prevent vomiting during chemotherapy.
It could also improve survival rates in women with early-stage breast cancer.
The strongest benefits were seen in those with triple negative breast cancer, a more aggressive form of the disease.
(Visited 39 times, 1 visits today)
Download Audio